Low molecular weight heparin use in COVID-19 is associated with curtailed viral persistence-a retrospective multicenter observational study.Pereyra D, Heber S, Schrottmaier WC, Santol J, Pirabe A, Schmuckenschlager A, Kammerer K, Ammon D, Sorz T, Fritsch F, Hayden H, Pawelka E, Krüger P, Rumpf B, Traugott MT, Glaser P, Firbas C, Schörgenhofer C, Seitz T, Karolyi M, Pabinger I, Brostjan C, Starlinger P, Weiss G, Bellmann-Weiler R, Salzer HJF, Jilma B, Zoufaly A, Assinger A.

Cardiovasc Res. 2021

Perioperative supplemental oxygen and NT-proBNP concentrations after major abdominal surgery – A prospective randomized clinical trial.Reiterer C, Kabon B, Taschner A, Falkner von Sonnenburg M, Graf A, Adamowitsch N, Starlinger P, Goshin J, Fraunschiel M, Fleischmann E.

J Clin Anesth. 2021

The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.Starlinger P, Ahn JC, Mullan A, Gyoeri GP, Pereyra D, Alva-Ruiz R, Hackl H, Reiberger T, Trauner M, Santol J, Simbrunner B, Mandorfer M, Berlakovich G, Kamath PS, Heimbach J.

Hepatology. 2021

Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysis.Driedger MR, Yamashita TS, Starlinger P, Mathis KL, Smoot RL, Cleary SP, Nagorney DM.

HPB (Oxford). 2021

Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis.Jonas JP, Hackl H, Pereyra D, Santol J, Ortmayr G, Rumpf B, Najarnia S, Schauer D, Brostjan C, Gruenberger T, Starlinger P.

HPB (Oxford). 2021

Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery.Starlinger P, Pereyra D, Hackl H, Ortmayr G, Braunwarth E, Santol J, Najarnia S, Driedger MR, Gregory L, Alva-Ruiz R, Glasgow A, Assinger A, Nagorney DM, Habermann EB, Staetttner S, Cleary SP, Smoot RL, Gruenberger T.

Hepatology. 2021

Finding the Balance: General Surgery Resident Versus Fellow Training and Exposure in Hepatobiliary and Pancreatic Surgery.Driedger MR, Groeschl R, Yohanathan L, Starlinger P, Grotz TE, Smoot RL, Nagorney DM, Cleary SP, Kendrick ML, Truty MJ.

J Surg Educ. 2021

Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases.Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A.

Int J Mol Sci. 2021

Combined APRI/ALBI score to predict mortality after hepatic resection.Starlinger P, Ubl DS, Hackl H, Starlinger J, Nagorney DM, Smoot RL, Habermann EB, Cleary SP.

BJS Open. 2021


Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study.Braunwarth E, Rumpf B, Primavesi F, Pereyra D, Hochleitner M, Göbel G, Gasteiger S, Gehwolf P, Öfner D, Starlinger P, Stättner S.

PLoS One. 2020

A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses.Stary V, Pandey RV, Strobl J, Kleissl L, Starlinger P, Pereyra D, Weninger W, Fischer GF, Bock C, Farlik M, Stary G.

Sci Immunol. 2020

Hemostasis and Liver Regeneration.Starlinger P, Luyendyk JP, Groeneveld DJ.

Semin Thromb Hemost. 2020

Impact of Anticoagulation and Sample Processing on the Quantification of Human Blood-Derived microRNA Signatures.Mussbacher M, Krammer TL, Heber S, Schrottmaier WC, Zeibig S, Holthoff HP, Pereyra D, Starlinger P, Hackl M, Assinger A.

Cells. 2020

The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P.

Hepatology. 2020

The effect of supplemental oxygen on perioperative brain natriuretic peptide concentration in cardiac risk patients – a protocol for a prosprective randomized clinical trial.Reiterer C, Kabon B, von Sonnenburg MF, Starlinger P, Taschner A, Zotti O, Goshin J, Drlicek G, Fleischmann E.

Trials. 2020

E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration.Sladky VC, Knapp K, Soratroi C, Heppke J, Eichin F, Rocamora-Reverte L, Szabo TG, Bongiovanni L, Westendorp B, Moreno E, van Liere EA, Bakker B, Spierings DCJ, Wardenaar R, Pereyra D, Starlinger P, Schultze S, Trauner M, Stojakovic T, Scharnagl H, Fava LL, Foijer F, de Bruin A, Villunger A. Dev Cell. 2020

Dev Cell. 2020


Predicting Postoperative Liver Dysfunction Based on Blood Derived MicroRNA Signatures. Starlinger P, Hackl H, Pereyra D, Skalicky S, Geiger E, Finsterbusch M, Tamandl D, Brostjan C, Grünberger T, Hackl M, Assinger A.

Hepatology 2019

Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans. Groeneveld D, Pereyra D, Veldhuis Z, Adelmeijer J, Ottens P, Kopec AK, Starlinger P, Lisman T, Luyendyk JP. (equally contributing last author)

Blood. 2019

Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgery.

Schweiger T, Liebmann-Reindl S, Glueck O, Starlinger P, Laengle J, Birner P, Klepetko W, Pils D, Streubel B, Hoetzenecker K. 

J Thorac Dis. 2018

The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.Pereyra D, Rumpf B, Ammann M, Perrodin SF, Tamandl D, Haselmann C, Stift J, Brostjan C, Laengle F, Beldi G, Gruenberger T, Starlinger P.

Ann Surg Oncol. 2019


Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection. Haegele S, Fuxsteiner J, Pereyra D, Koeditz C, Rumpf B, Schuetz C, Schwarz C, Brostjan C, Gruenberger T, Starlinger P.

Sci Rep. 2018

Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation. Seif K, Alidzanovic L, Tischler B, Ibrahim N, Zagrapan B, Rauscher S, Salzmann M, Hell L, Mauracher LM, Budde U, Schmid JA, Jilma B, Pabinger I, Assinger A, Starlinger P, Brostjan C.

Thromb Haemost. 2018

Responding to the challenges of international collaborations between the east and the west – report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators. Kataoka K, Kaider-Person O, Kasper B, Starlinger P, Caballero C, Menis J, Hendriks LE, Terada M, Collette L, Nakamura K, Lacombe D, Fukuda H.

Jpn J Clin Oncol. 2019 Jan

Mesh-augmented versus direct abdominal closure in patients undergoing open abdomen treatment. Jakob MO, Schwarz C, Haltmeier T, Zindel J, Pinworasarn T, Candinas D, Starlinger P, Beldi G.

Hernia. 2018

DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells.Laengle J, Stift J, Bilecz A, Wolf B, Beer A, Hegedus B, Stremitzer S, Starlinger P, Tamandl D, Pils D, Bergmann M.

Theranostics. 2018

Shaping the future of liver surgery: Implementation of experimental insights into liver regeneration. Pereyra D, Starlinger P.

Eur Surg. 2018

Reply to: “Intra-platelet serotonin in prognosis of tumorigenesis: Friend or foe?”

Pereyra D, Starlinger P.

J Hepatol. 2018


Pereyra D, Starlinger P.

Hepatology. 2018

Optimized plasma preparation is essential to monitor platelet-stored molecules in humans. Mussbacher M, Schrottmaier WC, Salzmann M, Brostjan C, Schmid JA, Starlinger P, Assinger A.

PLoS One. 2017

Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases. Stift J, Graf A, Schwarz C, Tamandl D, Starlinger P, Herac M, Beer A, Wrba F, Bodingbauer M, Kaczirek K, Stremitzer S.

Eur J Surg Oncol. 2018

Von Willebrand Factor Dynamics are Associated with Liver Regeneration and Predict Outcome after Liver Resection. Starlinger P, Pereyra D,  Haegele S, Braeuer P, Oehlberger L, Primavesi F, Kohler A, Offensperger F, Reiberger T, Ferlitsch A, Messner B, Beldi G, Staettner S, Brostjan C, Gruenberger T.

Hepatology 2018


Bivalent role of Intra-Platelet Serotonin in Liver Regeneration and Tumor Recurrence in Humans. Padickakudy R, Pereyra D, Offensperger F, Jonas P, Oehlberger L, Schwarz C, Haegele S, Assinger A, Brostjan C, Gruenberger T, Starlinger P.

J Hepatol. 2017

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss KH, Starlinger P, Pock H, Klöters-Plachky P, Gotthardt DN, Rauch P, Lackner C, Stift J, Brostjan C, Gruenberger T, Kumada T, Toyoda H, Tada T, Weiss TS, Trauner M, Mikulits W.

Oncotarget. 2017

Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity. Pereyra D, Offensperger F, Klinglmueller F, Haegele S, Oehlberger L, Gruenberger T, Brostjan C, Starlinger P.

PLoS One. 2017


The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. Schwabl P,Hambruch E,Seeland BA,Hayden H,Wagner M, Garnys L,Strobel B,Schubert TL,Riedl F,Mittereger D,Burnet M,Starlinger P,Oberhuber G,Deuschle U,Rohr-Udilova N, Podesser BK,Peck-Radosavljevic M, Reiberger T,Kremoser C,Trauner M.

J Hepatol. 2016

Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection. Haegele S, Reiter S, Wanek D, Offensperger F, Pereyra D, Stremitzer S, Fleischmann E, Brostjan C, Gruenberger T, Starlinger P. .

PLoS One. 2016

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance. Alidzanovic L, Starlinger P, Schauer D, Maier T, Feldman A, Buchberger E, Stift J, Koeck U, Pop L, Gruenberger B, Gruenberger T, Brostjan C. .

Oncotarget. 2016

Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response. Schauer D, Starlinger P, Alidzanovic L, Zajc P, Maier T, Feldman A, Padickakudy R, Buchberger E, Elleder V, Spittler A, Stift J, Pop L, Gruenberger B, Gruenberger T, Brostjan C. 

Oncoimmunology. 2016

Importance of platelet-derived growth factors in liver regeneration. Starlinger P, Assinger A.

Expert Rev Gastroenterol Hepatol. 2016

P2X1 regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration.Kudira R, Malinka T, Kohler A, Dosch M, Gomez de Agüero M, Melin N, Haegele S, Starlinger P, Maharjan N, Saxena S, Keogh A, Stroka D, Candinas D, Beldi G.

Hepatology. 2016

Defective intra-platelet vascular endothelial growth factor release is associated with liver dysfunction following partial hepatectomy. Starlinger P, Assinger A.

Hepatology. 2016


The Profile of Platelet alpha-Granule Released Molecules Affects Postoperative Liver Regeneration. P. Starlinger, S. Haegele, F. Offensperger, L. Oehlberger, D. Pereyra, J. B. Kral, W. C. Schrottmaier, S. Badrnya, T. Reiberger, A. Ferlitsch, J. Stift, F. Luf, C. Brostjan, T. Gruenberger, and A. Assinger. 

Hepatology 2015

Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. Stremitzer, S., J. Stift, J. Singh, P. Starlinger, B. Gruenberger, D. Tamandl, and T. Gruenberger. 

European journal of surgical oncology 2015

CEA Change After Neoadjuvant Chemotherapy Including Bevacizumab and Clinical Outcome in Patients Undergoing Liver Resection for Colorectal Liver Metastases. Stremitzer, S., J. Stift, A. Graf, J. Singh, P. Starlinger, B. Gruenberger, D. Tamandl, and T. Gruenberger. 2015.

Annals of surgical oncology 2015

Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction. Starlinger, P., S. Haegele, D. Wanek, S. Zikeli, D. Schauer, L. Alidzanovic, E. Fleischmann, B. Gruenberger, T. Gruenberger, and C. Brostjan.

The British journal of surgery 2015

Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases. Schweiger, T., C. Nikolowsky, P. Starlinger, D. Traxler, M. Zimmermann, P. Birner, B. Hegedus, B. Dome, M. Bergmann, M. Mildner, W. Klepetko, K. Hoetzenecker, and H. J. Ankersmit.

 PloS one 2015

Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study. Pilat, N., T. Grunberger, F. Langle, M. Mittlbock, B. Perisanidis, S. Kappel, B. Wolf, P. Starlinger, I. Kuhrer, F. Muhlbacher, and D. Kandioler. 

European journal of surgical oncology 2015

 Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer.Ilhan-Mutlu, A., P. Starlinger, T. Perkmann, S. F. Schoppmann, M. Preusser, and P. Birner. 

Biomarkers in medicine 2015

eficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction. Haegele, S., F. Offensperger, D. Pereyra, E. Lahner, A. Assinger, E. Fleischmann, B. Gruenberger, T. Gruenberger, C. Brostjan, and P. Starlinger. 

PloS one 2015


Reply. Starlinger, P., M. Lesurtel, C. Brostjan, P. A. Clavien, and T. Gruenberger.

Hepatology 2014

Role of platelets in systemic tissue protection after remote ischemic preconditioning. Starlinger, P., and T. Gruenberger.

Hepatology 2014

Starlinger, P., C. Brostjan, and T. Gruenberger. 2014. Evidence for serotonin as an inducer of liver regeneration in humans – further investigations. 

Hepatology 2014

 Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans. Starlinger, P., A. Assinger, S. Haegele, D. Wanek, S. Zikeli, D. Schauer, P. Birner, E. Fleischmann, B. Gruenberger, C. Brostjan, and T. Gruenberger.

Hepatology 2014

Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration. Schauer, D., P. Starlinger, P. Zajc, L. Alidzanovic, T. Maier, E. Buchberger, L. Pop, B. Gruenberger, T. Gruenberger, and C. Brostjan. 

BMC immunology 2014

Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. Reichl, P., M. Fang, P. Starlinger, K. Staufer, R. Nenutil, P. Muller, K. Greplova, D. Valik, S. Dooley, C. Brostjan, T. Gruenberger, J. Shen, K. Man, M. Trauner, J. Yu, C. F. Gao, and W. Mikulits.

International journal of cancer 2014


Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regeneration. Starlinger, P., D. Schauer, L. Alidzanovic, S. Zikeli, K. Gebhardt, F. Luf, E. Fleischmann, B. Perisanidis, B. Gruenberger, T. Gruenberger, and C. Brostjan.

Journal of hepatology 2013

Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancer. Perisanidis, C., M. Mittlbock, A. Schoppmann, G. Kornek, P. Starlinger, A. Stift, E. Selzer, C. Schopper, and R. Ewers. 

Clinical oral investigations 2013


Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation. Starlinger, P., L. Alidzanovic, D. Schauer, T. Maier, C. Nemeth, B. Perisanidis, D. Tamandl, B. Gruenberger, T. Gruenberger, and C. Brostjan.

British journal of cancer 2012

Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. Schauer, D., P. Starlinger, C. Reiter, N. Jahn, P. Zajc, E. Buchberger, T. Bachleitner-Hofmann, M. Bergmann, A. Stift, T. Gruenberger, and C. Brostjan.

PloS one 2012

Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Hoetzenecker, K., A. Assinger, M. Lichtenauer, M. Mildner, T. Schweiger, P. Starlinger, A. Jakab, E. Berenyi, N. Pavo, M. Zimmermann, C. Gabriel, C. Plass, M. Gyongyosi, I. Volf, and H. J. Ankersmit.

Basic research in cardiology 2012

Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Starlinger, P., P. Brugger, D. Schauer, S. Sommerfeldt, D. Tamandl, I. Kuehrer, S. F. Schoppmann, M. Gnant, and C. Brostjan.

Neoplasia 2012


Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Starlinger, P., P. Brugger, C. Reiter, D. Schauer, S. Sommerfeldt, D. Tamandl, I. Kuehrer, S. F. Schoppmann, M. Gnant, and C. Brostjan.

Neoplasia 2011

Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Starlinger, P., L. Alidzanovic, D. Schauer, P. Brugger, S. Sommerfeldt, I. Kuehrer, S. F. Schoppmann, M. Gnant, and C. Brostjan. 

Dis Markers 2011


S.ystemic effects of anti-VEGF therapy – Mini-reviewStarlinger P., G. K., Gruenberger T. , Brostjan C.

European Surgery 2010

Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. Starlinger, P., H. P. Moll, A. Assinger, C. Nemeth, K. Hoetzenecker, B. Gruenberger, T. Gruenberger, I. Kuehrer, S. F. Schoppmann, M. Gnant, and C. Brostjan. 

Journal of thrombosis and haemostasis 2010